Neoadjuvant chemotherapy for advanced oral cavity cancer

Affiliations

¹ Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
³ Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
⁴ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁵ Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Free article

Case Reports

Dan Yaniv et al. CA Cancer J Clin. 2024 May-Jun.

Free article

. 2024 May-Jun;74(3):213-223.

doi: 10.3322/caac.21829. Epub 2024 Feb 8.

¹ Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
³ Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
⁴ Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
⁵ Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

No abstract available

References

1. National Comprehensive Cancer Network (NCCN). Head and Neck Cancer, Version 2.2019. NCCN Clinical Practice Guidelines in Oncology. NCCN; 2019.
1. Gore SM, Crombie AK, Batstone MD, Clark JR. Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma. Head Neck. 2015;37(4):518‐523. doi:10.1002/hed.23626
1. Iyer NG, Tan DSW, Tan VK, et al. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10‐year update and subset analysis. Cancer. 2015;121(10):1599‐1607. doi:10.1002/cncr.29251
1. Chinn SB, Myers JN. Oral cavity carcinoma: current management, controversies, and future directions. J Clin Oncol. 2015;33(29):3269‐3276. doi:10.1200/jco.2015.61.2929
1. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high‐risk squamous‐cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937‐1944. doi:10.1056/nejmoa032646